Reply
Sir-We appreciate Dr. Štefanic's letter [1] proposing that statin-mediated inhibition of endothelial apoptosis may be a central mechanism for the decreased mortality rate observed among the bacteremic patients in our study [2] . Statins may alter neointimal thickness and stabilize atherosclerotic plaques through the reduction of apoptosis in vascular smooth-muscle cells [3, 4] , but there have been limited data on endothelial cell apoptosis [5] . It is premature to favor a single dominant mechanism when recent investigations reveal that the impact of statins seems to be multifaceted.
The diverse effects of statins on the host's inflammatory responses implicate multiple mechanisms rather than a single mechanism related to endothelial apoptosis. Independent of their lipid-lowering effects, statins have the potential to decrease isoprenylated proteins that are necessary for leukocyte cellular signaling, an important component of the inflammatory response. Recent studies have shown that statins modulate endothelial cell-adhesion molecules and block leukocyte integrins [6] [7] [8] , regulate chemotactic proteins [9] , and modulate proinflammatory cytokines [10] , in addition to being associated with other non-lipidlowering biologic effects. Whether any or all of these effects contributed to our finding of decreased mortality rates remains to be elucidated.
